15-22786677-A-AGCGGCGGCG
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP3BP6BS2
The NM_144599.5(NIPA1):c.39_47dupGGCGGCGGC(p.Ala14_Ala16dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00021 ( 0 hom., cov: 6)
Exomes 𝑓: 0.00022 ( 0 hom. )
Consequence
NIPA1
NM_144599.5 disruptive_inframe_insertion
NM_144599.5 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.48
Genes affected
NIPA1 (HGNC:17043): (NIPA magnesium transporter 1) This gene encodes a magnesium transporter that associates with early endosomes and the cell surface in a variety of neuronal and epithelial cells. This protein may play a role in nervous system development and maintenance. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene have been associated with autosomal dominant spastic paraplegia 6. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_144599.5
BP6
Variant 15-22786677-A-AGCGGCGGCG is Benign according to our data. Variant chr15-22786677-A-AGCGGCGGCG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 533362.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=2}.
BS2
High AC in GnomAd4 at 30 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIPA1 | NM_144599.5 | c.39_47dupGGCGGCGGC | p.Ala14_Ala16dup | disruptive_inframe_insertion | 1/5 | ENST00000337435.9 | NP_653200.2 | |
NIPA1 | NM_001142275.1 | c.-48+447_-48+455dupGGCGGCGGC | intron_variant | NP_001135747.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIPA1 | ENST00000337435.9 | c.39_47dupGGCGGCGGC | p.Ala14_Ala16dup | disruptive_inframe_insertion | 1/5 | 1 | NM_144599.5 | ENSP00000337452.4 | ||
NIPA1 | ENST00000437912.6 | c.-48+12382_-48+12390dupGGCGGCGGC | intron_variant | 1 | ENSP00000393962.2 | |||||
NIPA1 | ENST00000561183.5 | c.-48+447_-48+455dupGGCGGCGGC | intron_variant | 1 | ENSP00000453722.1 | |||||
NIPA1 | ENST00000560069.5 | n.31+447_31+455dupGGCGGCGGC | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000206 AC: 30AN: 145406Hom.: 0 Cov.: 6
GnomAD3 genomes
AF:
AC:
30
AN:
145406
Hom.:
Cov.:
6
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000218 AC: 202AN: 926066Hom.: 0 Cov.: 3 AF XY: 0.000228 AC XY: 101AN XY: 442810
GnomAD4 exome
AF:
AC:
202
AN:
926066
Hom.:
Cov.:
3
AF XY:
AC XY:
101
AN XY:
442810
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000206 AC: 30AN: 145488Hom.: 0 Cov.: 6 AF XY: 0.000170 AC XY: 12AN XY: 70786
GnomAD4 genome
AF:
AC:
30
AN:
145488
Hom.:
Cov.:
6
AF XY:
AC XY:
12
AN XY:
70786
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Feb 01, 2020 | - - |
Hereditary spastic paraplegia 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2025 | This variant, c.39_47dup, results in the insertion of 3 amino acid(s) of the NIPA1 protein (p.Ala14_Ala16dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with NIPA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 533362). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 19, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 07, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at